Dan David of Wolfpack Research makes the case that B. Riley Financial’s (RILY) foray into lending to highly speculative public companies, such as SPACs, imperils its balance sheet.
Enter your email address to receive notifications of the latest short-selling news by email.
Dan David of Wolfpack Research makes the case that B. Riley Financial’s (RILY) foray into lending to highly speculative public companies, such as SPACs, imperils its balance sheet.
Recent Comments